Imunon Inc (IMNN) stock news · rev $500.0K
Imunon Inc (IMNN) is a biotechnology company listed on US.
This IMNN news page leads with what Imunon Inc filed — not a scraped headline mill.
No cached 8-K sentence for IMNN yet. We will not pad this page with generic market recap.
Latest reported IMNN revenue for 2022-12-31 was $500.0K. Net income was -$35.9M. Revenue was up 0.0% from 2021-12-31 to 2022-12-31. IMNN currently screens at market cap $9.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMNN stock page; for the tape open the quote page.
IMNN stock news FAQ
What are IMNN's latest revenue and net income?
Latest cached Imunon Inc (IMNN) revenue for Dec 31, 2022 was $500.0K. Net income was -$35.9M. Statements: https://lician.com/financials/imnn
How did IMNN revenue change from the prior cached period?
Cached Imunon Inc (IMNN) revenue was unchanged from $500.0K (Dec 31, 2021) to $500.0K (Dec 31, 2022). Statements: https://lician.com/financials/imnn
What is IMNN's market cap?
Imunon Inc (IMNN) market cap is $9.2M on the latest cached fundamentals snapshot.
What kind of company is IMNN?
Imunon Inc (IMNN) is a biotechnology company listed on US.
Where is IMNN stock news listed?
Cached stock news for Imunon Inc (IMNN) is listed at https://lician.com/news/imnn. Filings: https://lician.com/sec/imnn
Not investment advice.